Dyne Therapeutics, Inc. Net Debt

Net Debt of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt growth rates and interactive chart. Net debt is the sum of all interest-bearing debt (short-term and long-term) minus cash and short-term investments. A positive number indicates the company's total debt exceeds its cash and short-term investments balances, while a negative number means the company has more cash than its total debt. This figure is also used in Enterprise value calculation.

Highlights and Quick Summary

  • Net Debt for the quarter ending June 30, 2023 was $-179 Million (a -14.27% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt decreased by -17.63%
  • Annual Net Debt for 2022 was $-226 Million (a -34.43% decrease from previous year)
  • Annual Net Debt for 2021 was $-344 Million (a -0.4% decrease from previous year)
  • Annual Net Debt for 2020 was $-345 Million (a 2259.99% increase from previous year)
Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt of Dyne Therapeutics, Inc.

Most recent Net Debtof DYN including historical data for past 10 years.

Interactive Chart of Net Debt of Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. Net Debt for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-178.7 $-208.45 – – –
2022 $-225.53 $-216.95 $-259.0 $-290.37 $-225.53
2021 $-343.94 $-373.52 $-435.19 $-482.49 $-343.94
2020 – – $-345.31 $-369.67 $-345.31
2019 – – – $-14.63 $-14.63
2018 – – – – $-4.75

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com